propidium has been researched along with gambogic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Chen, Z; Ke, WJ; Wang, Y; Wu, Q; Wu, QL | 1 |
| Gu, H; Guo, Q; Ling, H; Liu, W; Lu, N; Mu, R; Qi, Q; Rao, S; Ren, FL; Wang, J; Wang, X; Yang, Y; You, Q; Zhao, J | 1 |
2 other study(ies) available for propidium and gambogic acid
| Article | Year |
|---|---|
Gambogic acid induces death inducer-obliterator 1-mediated apoptosis in Jurkat T cells.
Topics: Annexin A5; Apoptosis; Bisbenzimidazole; Caspase 3; Cell Nucleus; Cell Proliferation; Cell Survival; DNA Fragmentation; DNA-Binding Proteins; Dose-Response Relationship, Drug; Down-Regulation; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Formazans; Humans; Inhibitory Concentration 50; Jurkat Cells; Molecular Structure; NF-kappa B; Propidium; Proto-Oncogene Proteins c-bcl-2; T-Lymphocytes; Tetrazolium Salts; Xanthones | 2008 |
Gambogic acid mediates apoptosis as a p53 inducer through down-regulation of mdm2 in wild-type p53-expressing cancer cells.
Topics: Animals; Annexin A5; Antineoplastic Agents; Apoptosis; Cell Proliferation; Down-Regulation; Humans; Male; Mice; Mice, Inbred BALB C; Neoplasms; Propidium; Proto-Oncogene Proteins c-mdm2; Transcription, Genetic; Tumor Suppressor Protein p53; Up-Regulation; Xanthones; Xenograft Model Antitumor Assays | 2008 |